112 related articles for article (PubMed ID: 2617477)
1. Protein C: Rouen, a new hereditary protein C abnormality with low anticoagulant but normal amidolytic activities.
Vasse M; Borg JY; Monconduit M
Thromb Res; 1989 Nov; 56(3):387-98. PubMed ID: 2617477
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional activated protein C (PC Cádiz) in a patient with thrombotic disease.
Sala N; Borrell M; Bauer KA; Viganò-D'Angelo S; Fontcuberta J; Félez J; Rutllant ML
Thromb Haemost; 1987 Apr; 57(2):183-6. PubMed ID: 3037717
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
Johnstone IB; Martin CA
Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
[TBL] [Abstract][Full Text] [Related]
4. Fast functional assay of protein C in whole plasma using a snake venom activator: evaluation in patients with congenital and acquired protein C deficiencies.
Takahashi H; Hanano M; Tatewaki W; Shibata A
Clin Chim Acta; 1988 Jul; 175(3):217-25. PubMed ID: 3416483
[TBL] [Abstract][Full Text] [Related]
5. Cohn process influences the functional anticoagulant activity of human protein C.
Wang ZK; Du X; Wang YM; Li CQ; Lin FZ; Cao HJ; Ye SL; Hu JJ; Yuan J
Genet Mol Res; 2015 Feb; 14(1):860-70. PubMed ID: 25730025
[TBL] [Abstract][Full Text] [Related]
6. A new hereditary abnormal protein C (protein C Yonago) with a dysfunctional Gla-domain.
Iijima K; Fukuda C; Nakamura K; Kanaoka Y; Ohgi S; Mori T
Thromb Res; 1991 Jul; 63(2):249-57. PubMed ID: 1771629
[TBL] [Abstract][Full Text] [Related]
7. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.
Preston RJ; Morse C; Murden SL; Brady SK; O'Donnell JS; Mumford AD
Br J Haematol; 2009 Mar; 144(6):946-53. PubMed ID: 19133979
[TBL] [Abstract][Full Text] [Related]
8. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
Nishioka J; Ido M; Hayashi T; Suzuki K
Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
[TBL] [Abstract][Full Text] [Related]
9. A family with an abnormal protein C and a thrombotic tendency.
Girolami A; Simioni P; Lazzaro AR; Girolami B; Prandoni P
Haematologia (Budap); 1993; 25(1):25-33. PubMed ID: 8339996
[TBL] [Abstract][Full Text] [Related]
10. Protein C Thr315Ala variant results in gain of function but manifests as type II deficiency in diagnostic assays.
Ding Q; Yang L; Dinarvand P; Wang X; Rezaie AR
Blood; 2015 Apr; 125(15):2428-34. PubMed ID: 25651845
[TBL] [Abstract][Full Text] [Related]
11. Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.
Chen C; Yang L; Villoutreix BO; Wang X; Ding Q; Rezaie AR
Thromb Haemost; 2017 Jun; 117(7):1358-1369. PubMed ID: 28405673
[TBL] [Abstract][Full Text] [Related]
12. Automated amidolytic method for evaluating the activated partial thromboplastin time compared with a conventional coagulation method.
Tripodi A; Poggio M; Scapellato L; Mannucci PM
Haemostasis; 1989; 19(4):205-12. PubMed ID: 2509308
[TBL] [Abstract][Full Text] [Related]
13. [Study of chromogenic substrate on protein C activity assay--in patients treated with warfarin].
Sakata T; Hatsuyama H; Kitamura T; Uchida K; Katayama Y; Matsuyama T
Rinsho Byori; 1990 Aug; 38(8):937-41. PubMed ID: 2232257
[TBL] [Abstract][Full Text] [Related]
14. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis.
Tripodi A; Primignani M; Lemma L; Chantarangkul V; Mannucci PM
J Hepatol; 2013 Aug; 59(2):265-70. PubMed ID: 23583273
[TBL] [Abstract][Full Text] [Related]
15. Protein C deficiency resulting from possible double heterozygosity and its response to danazol.
Gruppo RA; Leimer P; Francis RB; Marlar RA; Silberstein E
Blood; 1988 Feb; 71(2):370-4. PubMed ID: 3337902
[TBL] [Abstract][Full Text] [Related]
16. Treatment with stanozolol of type I protein C deficiency in an Italian family.
Mannucci PM; Bottasso B; Sharon C; Tripodi A
Ric Clin Lab; 1984; 14(4):673-80. PubMed ID: 6549220
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant dysfunction of human Arg352Trp-activated protein C caused by defective factor Va inactivation.
Rintelen C; Yegneswaran S; Griffin JH
Thromb Haemost; 2001 Feb; 85(2):274-9. PubMed ID: 11246547
[TBL] [Abstract][Full Text] [Related]
18. Activated protein C resistance--a major risk factor for thrombosis.
Rosén SB; Sturk A
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
[TBL] [Abstract][Full Text] [Related]
19. Functional assays of protein C: comparison of two snake-venom assays with two thrombin assays.
Franchi F; Tripodi A; Valsecchi C; Mannucci PM
Thromb Haemost; 1988 Oct; 60(2):145-7. PubMed ID: 3217914
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Hereditary Thrombophilia: Performance of Protein C (PC) Testing.
Marlar RA; Gausman JN
Methods Mol Biol; 2017; 1646():145-151. PubMed ID: 28804825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
